Clinical trials
Respiratory Aspiration trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Unknown status | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo General Hospital | 5 |
| Hospital de Clinicas de Porto Alegre | 3 |
| Hospital Israelita Albert Einstein | 2 |
| Universidade Federal Fluminense | 2 |
| Universidade Federal do Rio de Janeiro | 2 |
| Centro de Estudos em Medicina Comportamental | 1 |
| Hospital do Coracao | 1 |
| Immune Biosolutions Inc | 1 |
| Instituto Dante Pazzanese de Cardiologia | 1 |
| Pericles Almeida Delfino Duarte | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Aspiration | 25 |
| Respiratory Insufficiency | 4 |
| Mouth Breathing | 2 |
| Respiratory Distress Syndrome | 2 |
| Anxiety Disorders | 1 |
| Bronchiolitis | 1 |
| COVID-19 | 1 |
| Dyspnea | 1 |
| Panic Disorder | 1 |
| Respiration Disorders | 1 |
Trials
Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.